In 2014 the Ministry of Public Health and Hygiene of Mali signed a decree to establish the NITAG. Four years later, the Ministry of Health nominates the 13 core members as well as the ex-officio and liaision members.
The Joint Committee on Vaccination and Immunisations (JCVI) has recommended that the HPV immunisation programme should be extended to cover boys.
On 16th May 2018, the Honorable minister of Health inaugurated NITAG-Ghana at the MoH conference room. Thus, Ghana took a bold step to join GAVI-eligible countries in sub-Saharan Africa to establish a National Immunization Technical Advisory Group (NITAG).
New study on the introduction of rotavirus vaccine in the national immunization programs of Finland, Denmark, Norway and Sweden05.28.2018
This study illustrates how four countries with comparable public health-care systems and similar burden of rotavirus disease arrive at different decisions regarding potential introduction of rotavirus vaccine in the NIP.
With 22 small countries/territories, the Caribbean faced a great challenge in stablishing NITAGs. Given the history of Caribbean countries working successfully together in health, the Health Ministers took the wise decision in 2017 to establish a sub-regional NITAG. This is an efficient mechanism to provide independent advice on immunization to the Ministers of Health in keeping with the recommendations of the Global Vaccine Action Plan (GVAP) and PAHO’S Regional Immunization Action Plan (RIAP).
This position paper replaces the 2004 WHO position paper on Bacille Calmette-Guérin (BCG) vaccine and the 2007 WHO revised BCG vaccination guidelines for infants at risk for human immunodeficiency virus (HIV) infection. It incorporates recent developments in the field of tuberculosis, provides revised guidance on the immunization of children infected with HIV, and re-emphasizes the importance of the BCG birth dose.
A unique training for NITAG was organized in Beijing on December 12-14 2017. For the first time, the training gathered together NITAG chair and members but also the working group leaders, ex-officio members and liaison members as well as NITAG from other countries as facilitators.
The Partnership for Influenza Vaccine Introduction (PIVI), based at The Task Force for Global Health (TFGH), is an innovative public/private program that partners with the Centers for Disease Control and Prevention (CDC), Ministries of Health, corporate partners and others to create sustainable, routine, seasonal influenza vaccination programs in low- and middle-income countries. PIVI’s goal is to create routine, seasonal influenza vaccination programs to protect communities from the impacts of both seasonal and pandemic influenza. Working with countries’ Ministries of Health, as well as with other technical collaborators, PIVI supports capacity building for NITAGs to make evidence-based vaccine policy decision making. These activities are coordinated with NITAG strengthening work carried out through other projects and cooperative funding agreements between countries and CDC’s Influenza and Global Immunization Divisions. The work is also closely coordinated with NITAG focal points in WHO regional and country offices.